Trials / Unknown
UnknownNCT00339118
EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Sheba Medical Center · Other Government
- Sex
- All
- Age
- 6 Months – 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is achieve standardization treatment of low and intermediate risk rhabdomyosarcoma patients, with an attempt to improve treatment results in high and very high risk patients by the addition of doxorubicin as induction treatment and at the maintenance phase.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | doxorubicin, cytoxan |
Timeline
- First posted
- 2006-06-20
- Last updated
- 2006-06-20
Source: ClinicalTrials.gov record NCT00339118. Inclusion in this directory is not an endorsement.